SOCS-1 inhibits expression of the antiviral proteins 2′,5′-OAS and MxA induced by the novel interferon-λs IL-28A and IL-29

Biochemical and Biophysical Research Communications

Volumn 331, Issue 2, 2005, Pages 543-548

  Brand, Stephan ^a   Zitzmann, Kathrin ^a   Dambacher, Julia ^a   Beigel, Florian ^a   Olszak, Torsten ^a   Vlotides, George ^a   Eichhorst, Sören T ^a   Göke, Burkhard ^a   Diepolder, Helmut ^a   Auernhammer, Christoph J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

2 ,5 OAS; Hepatitis C virus; IFN ; IL 28A; IL 29; MxA; SOCS 1; SOCS 3; STAT1; STAT3

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; MESSENGER RNA; STAT1 PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; VIRUS PROTEIN;

ARTICLE; CELL LINE; CELL STRAIN HEPG2; CONTROLLED STUDY; EVALUATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEMATOPOIETIC CELL; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; VIRUS HEPATITIS; VIRUS INHIBITION; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 20944448432     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.04.004     Document Type: Article

References (25)

1. B. Rehermann, and M. Nascimbeni Immunology of hepatitis B virus and hepatitis C virus infection Nat. Rev. Immunol. 5 2005 215 229
2. NIH Consensus Statement on Management of Hepatitis C: 2002, NIH Consens State Sci Statements 19 (2002) 1-46
3. M. Chiaramonte, T. Stroffolini, A. Vian, M.A. Stazi, A. Floreani, U. Lorenzoni, S. Lobello, F. Farinati, and R. Naccarato Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis Cancer 85 1999 2132 2137
4. Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. International Interferon-alpha Hepatocellular Carcinoma Study Group, Lancet 351 (1998) 1535-1539
5. M.P. Manns, J.G. McHutchison, S.C. Gordon, V.K. Rustgi, M. Shiffman, R. Reindollar, Z.D. Goodman, K. Koury, M. Ling, and J.K. Albrecht Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 2001 958 965
6. M.W. Fried, M.L. Shiffman, K.R. Reddy, C. Smith, G. Marinos, F.L. Goncales Jr., D. Haussinger, M. Diago, G. Carosi, D. Dhumeaux, A. Craxi, A. Lin, J. Hoffman, and J. Yu Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N. Engl. J. Med. 347 2002 975 982
7. K.L. Lindsay Introduction to therapy of hepatitis C Hepatology 36 2002 S114 S120
8. J.G. Bode, S. Ludwig, C. Ehrhardt, U. Albrecht, A. Erhardt, F. Schaper, P.C. Heinrich, and D. Haussinger IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3 FASEB J. 17 2003 488 490
9. G. Vlotides, A.S. Sorensen, F. Kopp, K. Zitzmann, N. Cengic, S. Brand, R. Zachoval, and C.J. Auernhammer SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA Biochem. Biophys. Res. Commun. 320 2004 1007 1014
10. C.J. Auernhammer, and S. Melmed The central role of SOCS-3 in integrating the neuro-immunoendocrine interface J. Clin. Invest. 108 2001 1735 1740
11. S.V. Kotenko, G. Gallagher, V.V. Baurin, A. Lewis-Antes, M. Shen, N.K. Shah, J.A. Langer, F. Sheikh, H. Dickensheets, and R.P. Donnelly IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex Nat. Immunol. 4 2003 69 77
12. P. Sheppard, W. Kindsvogel, W. Xu, K. Henderson, S. Schlutsmeyer, T.E. Whitmore, R. Kuestner, U. Garrigues, C. Birks, J. Roraback, C. Ostrander, D. Dong, J. Shin, S. Presnell, B. Fox, B. Haldeman, E. Cooper, D. Taft, T. Gilbert, F.J. Grant, M. Tackett, W. Krivan, G. McKnight, C. Clegg, D. Foster, and K.M. Klucher IL-28, IL-29 and their class II cytokine receptor IL-28R Nat. Immunol. 4 2003 63 68
13. E.M. Coccia, M. Severa, E. Giacomini, D. Monneron, M.E. Remoli, I. Julkunen, M. Cella, R. Lande, and G. Uze Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells Eur. J. Immunol. 34 2004 796 805
14. K. Imanaka, S. Tamura, K. Fukui, N. Ito, S. Kiso, Y. Imai, T. Naka, T. Kishimoto, S. Kawata, and Y. Shinomura Enhanced expression of suppressor of cytokine signalling-1 in the liver of chronic hepatitis C: possible involvement in resistance to interferon therapy J. Viral. Hepat. 12 2005 130 138
15. S. Brand, F. Beigel, J. Dambacher, T. Olszak, S.T. Eichhorst, K. Zitzmann, B. Göke, C. Auernhammer, H. Diepolder, The novel cytokines IL-28A and IL-29 exhibit antiproliferative and antiviral properties in liver cells (abstract). Gastroenterology 128 (4), Suppl.; Program of the annual meeting of: The American Gastroenterological Association and Digestive Disease Week, Chicago, May 14-19, 2005 (2005)
16. M.D. Robek, B.S. Boyd, and F.V. Chisari Lambda interferon inhibits hepatitis B and C virus replication J. Virol. 79 2005 3851 3854
17. S. Brand, T. Sakaguchi, X. Gu, S.P. Colgan, and H.C. Reinecker Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells Gastroenterology 122 2002 166 177
18. L.B. Seeff Natural history of chronic hepatitis C Hepatology 36 2002 S35 S46
19. W. Ray Kim Global epidemiology and burden of hepatitis C Microbes Infect. 4 2002 1219 1225
20. S. Brand, F. Beigel, T. Olszak, K. Zitzmann, S.T. Eichhorst, J.M. Otte, B. Goeke, H. Diepolder, B. Adler, J. Dambacher, C. Auernhammer, The novel Lambda-interferons IL-28A and IL-29 mediate proinflammatory, antiproliferative and antiviral signals in intestinal epithelial cells, unpublished results
21. R.P. Donnelly, F. Sheikh, S.V. Kotenko, and H. Dickensheets The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain J. Leukoc. Biol. 76 2004 314 321
22. J.E. Darnell Jr., I.M. Kerr, and G.R. Stark Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 264 1994 1415 1421
23. F.H. Duong, M. Filipowicz, M. Tripodi, N. La Monica, and M.H. Heim Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A Gastroenterology 126 2004 263 277
24. A. Blindenbacher, F.H. Duong, L. Hunziker, S.T. Stutvoet, X. Wang, L. Terracciano, D. Moradpour, H.E. Blum, T. Alonzi, M. Tripodi, N. La Monica, and M.H. Heim Expression of hepatitis C virus proteins inhibits interferon alpha signaling in the liver of transgenic mice Gastroenterology 124 2003 1465 1475
25. Y. Ding, D. Chen, A. Tarcsafalvi, R. Su, L. Qin, and J.S. Bromberg Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses J. Immunol. 170 2003 1383 1391